Assessment of the efficacy and accuracy of cervical cytology screening with the Hologic Genius Digital Diagnostics System
Cancer Cytopathology · 2025
DOI: 10.1002/cncy.70022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cytopathology, 2025. Verfasst von Esther Elishaev und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, UPMC Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papanicolaou Test, Early Detection of Cancer, Atypical Squamous Cells of the Cervix. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Medical technologies powered by artificial intelligence are quickly transforming into practical solutions by rapidly leveraging massive amounts of data processed via deep learning algorithms. There is a necessity to validate these innovative tools when integrated into clinical practice.
Methods
This study evaluated the performance of the Hologic Genius Digital Diagnostics System (HGDDS) with a cohort of 890 previously reviewed and diagnosed ThinPrep Papanicolaou (Pap) tests with the intent to deploy this system for routine clinical use. The study included all diagnostic categories of The Bethesda System, with follow‐up tissue sampling performed within 6 months of abnormal Pap test results to serve as the ground truth.
Results
The HGDDS demonstrated excellent performance in detecting significant Pap test findings, with close to 100% sensitivity (98.2%–100%) for cases classified as atypical squamous cells of undetermined significance and above within a 95% confidence interval and a high negative predictive value (92.4%–100%).
Conclusions
The HGDDS streamlined workflow, reduced manual workload, and functioned as a stand‐alone system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, UPMC Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- Department of Pathology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
- Scientific Affairs, Hologic, Inc, Marlborough, Massachusetts, USA.
ORCID-Profile: Esther Elishaev, Lakshmi Harinath, Liron Pantanowitz, Chengquan Zhao
Zitieren
APA
Elishaev, E., Harinath, L., Ye, Y., Matsko, J., Colaizzi, A., Wharton, S., Bhargava, R., Pantanowitz, L., Hanna, M. G., Harrington, S., & Zhao, C. (2025). Assessment of the efficacy and accuracy of cervical cytology screening with the Hologic Genius Digital Diagnostics System. Cancer Cytopathology. https://doi.org/10.1002/cncy.70022
Vancouver
Elishaev E, Harinath L, Ye Y, Matsko J, Colaizzi A, Wharton S, et al. Assessment of the efficacy and accuracy of cervical cytology screening with the Hologic Genius Digital Diagnostics System. Cancer Cytopathology. 2025. doi:10.1002/cncy.70022
BibTeX
@article{Elishaev2025,
author = {Elishaev, Esther and Harinath, Lakshmi and Ye, Yuhong and Matsko, Jonee and Colaizzi, Amy and Wharton, Stephanie and Bhargava, Rohit and Pantanowitz, Liron and Hanna, Matthew G and Harrington, Sarah and Zhao, Chengquan},
title = {Assessment of the efficacy and accuracy of cervical cytology screening with the Hologic Genius Digital Diagnostics System},
journal = {Cancer Cytopathology},
year = {2025},
doi = {10.1002/cncy.70022}
}
EUVIMED